Post by
GoBBs on Nov 13, 2020 7:17pm
Some new docs on Sedar,
This a read, Galbraiths statement about the new PDUFA
“While we are disappointed by the extension of the review period by FDA, we look forward to continuing discussions with the FDA during the review process,” said Kenneth Galbraith, Chief Executive Officer of Liminal BioSciences. “We remain committed to bringing this much needed treatment forward to help patients with this serious disease.”
Also, fun fact Thomvest is located at 65 Queen St W, Toronto ...... which is in "The Thomson Building".
Comment by
ifso on Nov 14, 2020 11:43am
"65 Queen St W, Toronto ...... which is in "The Thomson Building": A 10 minutes walk from Arrow-Capital that seems to be behind Curvature Hedge Strategies (The guys who did short Prometic). Wondering if those guys from Thomvest aren't taking a coffee with people from Curvature once in a while. It's a small world: Concidences happen.
Comment by
4Justice on Nov 14, 2020 3:56pm
I know some lawyers that would be interested to know more about who shorted PLI in 2017-2018
Comment by
Sterling547 on Nov 14, 2020 4:12pm
This post has been removed in accordance with Community Policy
Comment by
ifso on Nov 14, 2020 8:22pm
Here is for your lawyers. In the text, when you will see "Curvature hedge", click on that link and see how they use computers to trade for them. https://www.cantechletter.com/2018/05/prometic-life-sciences-is-just-too-risky-this-fund-manager-says/
Comment by
ifso on Nov 14, 2020 8:44pm
Forget about the part where I wrote "See how thwy use computers to trade for them". I can't find wher I saw that. Sorry.
Comment by
4Justice on Nov 15, 2020 4:43pm
Thanks IFSO Is the office of Curvature close to the building where is located Tomvest ? Do you know some relationship between these two company ? I've access to some informations confirming that the date of this Cantech letter is "important"